Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Selleck Chemical LLC LQZ-7I-E0108-25MG
SDP

Catalog No. 503134708
Encompass_Preferred

LQZ-7I is a novel selectively inhibitor of survivin dimerization with IC50s of 4 8 M and 3 1 M in prostate cancer cell lines PC-3 and C4-2 respectively LQZ-7I orally effectively inhibits xenograft tumor growth and induces survivin loss in tumors

Catalog No. 50-313-4708 Supplier Selleck Chemical LLC Supplier No. E010825MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

LQZ-7I is a novel selectively inhibitor of survivin dimerization with IC50s of 4 8 M and 3 1 M in prostate cancer cell lines PC-3 and C4-2 respectively LQZ-7I orally effectively inhibits xenograft tumor growth and induces survivin loss in tumors

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.